Affiliations: Chair Jean Monnet "Europe of the Health", Granada,
Spain. E-mail: jlvalver@ugr.es
Abstract: The conclusions of The House of Commons Science and Technology
Committee report examining the policy on homeopathy, it is a careful and
thoughtful analysis. It is the best example of the responsibility of the
Parliaments for protects the health right of the patients. His proposals will
be valid for all the countries and will be global principle for regulation. It
is unacceptable for the National Health Authorities to license placebo products
conferring upon them some of the status of medicines. Even if medical claims on
labels are prohibited, the official licensing itself lends direct credibility
to a product. Licensing paves the way for retail in pharmacies and consequently
the patient's view of the credibility of homeopathy may be further enhanced.
The Governments runs the risk of endorsing homeopathy as an efficacious system
of medicine. It is time to break this chain. Homeopathy should not be funded
and the Agencies of Medicaments should stop licensing homeopathic products. Not changes the actual situation will lose the credibility of the Health
Institutions. It is one more political inconsistency.